Carfilzomib is superior to bortezomib in rMM
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2016.136
Published Online: 2016-08-23
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2016-08-23
Article History
First Online: 23 August 2016